|
| 36089700 | Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID. | J Infect Dis | 2023 |
| 38019897 | A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size. | PLoS Pathog | 2023 |
| 37667052 | SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). | Nat Immunol | 2023 |
| 37961239 | Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection. | medRxiv | 2023 |
| 37848036 | Serotonin reduction in post-acute sequelae of viral infection. | Cell | 2023 |
| 37988251 | The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms. | J Med Virol | 2023 |
| 37723351 | Author Correction: SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). | Nat Immunol | 2023 |
| 37119030 | SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency. | Am J Epidemiol | 2023 |
| 36947108 | Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC). | Elife | 2023 |
| 37468623 | A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection. | Nature | 2023 |
| 37243212 | Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies. | Viruses | 2023 |
| 37205522 | Association of SARS-CoV-2 Infection and Cardiopulmonary Long COVID with Exercise Capacity and Chronotropic Incompetence among People with HIV. | medRxiv | 2023 |
| 37233729 | Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC). | Elife | 2023 |
| 37166076 | Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmonary Phenotype Long Coronavirus Disease 2019. | J Infect Dis | 2023 |
| 36881933 | Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding During Suppressive Antiretroviral Therapy. | J Infect Dis | 2023 |
| 36695358 | Host variation in type I interferon signaling genes (MX1), C-C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size. | AIDS | 2023 |
| 36712077 | Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection. | bioRxiv | 2023 |
| 36798288 | Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients. | medRxiv | 2023 |
| 36798286 | Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. | bioRxiv | 2023 |
| 36454631 | Chronic viral coinfections differentially affect the likelihood of developing long COVID. | J Clin Invest | 2023 |
| 34780969 | Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. | Transl Res | 2022 |
| 35800257 | Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies. | Pathog Immun | 2022 |
| 35701186 | Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. | Neurol Neuroimmunol Neuroinflamm | 2022 |
| 35727635 | Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. | JCI Insight | 2022 |
| 35855168 | Rapid sequential development and rupture of mycotic aneurysms within a period of days in a patient with graft-versus-host disease and angiotropic <i>Scedosporium apiospermum</i> infection. | Surg Neurol Int | 2022 |
| 35426225 | COVID-19 in vaccinated versus unvaccinated hematologic malignancy patients. | Transpl Infect Dis | 2022 |
| 35389890 | Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection. | JCI Insight | 2022 |
| 36134654 | Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling. | JCI Insight | 2022 |
| 35866847 | Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection. | AIDS | 2022 |
| 35898346 | Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID. | medRxiv | 2022 |
| 35316218 | Rapamycin limits CD4+ T cell proliferation in simian immunodeficiency virus-infected rhesus macaques on antiretroviral therapy. | J Clin Invest | 2022 |
| 35043593 | Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID-19. | Ann Clin Transl Neurol | 2022 |
| 34918211 | Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery. | Int J Behav Med | 2022 |
| 35285072 | SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19. | Ann Neurol | 2022 |
| 35264559 | First-in-human immunoPET imaging of HIV-1 infection using <sup>89</sup>Zr-labeled VRC01 broadly neutralizing antibody. | Nat Commun | 2022 |
| 34864962 | Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study. | Clin Infect Dis | 2022 |
| 34617982 | Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms. | Clin Infect Dis | 2022 |
| 32780519 | Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. | Am J Transplant | 2021 |
| 33767397 | Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection. | Nat Biotechnol | 2021 |
| 33758895 | Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19. | medRxiv | 2021 |
| 33758881 | Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study. | medRxiv | 2021 |
| 33564754 | Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. | Res Sq | 2021 |
| 33536176 | Evaluating a New Class of AKT/mTOR Activators for HIV Latency Reversing Activity <i>Ex Vivo and In Vivo</i>. | J Virol | 2021 |
| 33668514 | Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. | Cells | 2021 |
| 33528824 | Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. | J Neurovirol | 2021 |
| 33688685 | Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19. | medRxiv | 2021 |
| 35106317 | Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. | Open Forum Infect Dis | 2021 |
| 34545373 | SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency. | medRxiv | 2021 |
| 34395717 | Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. | Open Forum Infect Dis | 2021 |
| 34677601 | Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. | J Infect Dis | 2021 |